Cargando...
Antithrombotic therapy in diabetes: which, when, and for how long?
Cardiovascular disease remains the main cause of mortality in individuals with diabetes mellitus (DM) and also results in significant morbidity. Premature and more aggressive atherosclerotic disease, coupled with an enhanced thrombotic environment, contributes to the high vascular risk in individual...
Gardado en:
| Publicado en: | Eur Heart J |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8203081/ https://ncbi.nlm.nih.gov/pubmed/33764414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehab128 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|